IP Library Granted Patent US 7,320,894
Granted Patent B2
US 7,320,894 · App. 10/441,089 · Granted Jan 22, 2008

Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor

Assignee: DRG International, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,320,894
App. No.
10/441,089
Granted
Jan 22, 2008
Kind
B2
Abstract

The present invention concerns methods and kits for diagnosing a disease condition characterized by non-physiological levels of hepcidin, comprising obtaining a tissue or fluid sample from a subject; contacting the sample with an antibody or fragment thereof that specifically binds to a polypeptide corresponding to the mid-portion or C terminus of a hepcidin protein, and quantifying the hepcidin level using an assay based on binding of the antibody and the polypeptide; wherein the non-physiological level of hepcidin is indicative of the disease condition. The present invention also concerns diagnostic methods and kits for applications in genetic technological approaches, such as for overexpressing or downregulating hepcidin. The present invention further concerns therapeutic treatment of certain diseases by treatment of subjects with hepcidin and agonists or antagonists of hepcidin.

Claims (8)

1. A kit for detecting a disease condition characterized by non-physiological levels of hepcidin, comprising, an anti-hepcidin antibody or fragment thereof that specifically binds to one or more epitopes of hepcidin located within amino acids 70-84 of SEQ ID NO: 2, and a reagent that binds directly or indirectly to the antibody or fragment thereof.

2. The kit of claim 1 wherein the anti-hepcidin antibody or fragment thereof is immobilized on a support.

3. The kit of claim 1 wherein the reagent comprises hepcidin complexed with a first binding molecule.

4. The kit of claim 3 wherein the first binding molecule is biotin.

5. The kit of claim 4 wherein the kit further comprises an enzyme complexed with a second binding molecule and a substrate of the enzyme.

6. The kit of claim 5 , wherein the second binding molecule is streptavidin.

7. The kit of claim 5 , wherein the enzyme is horse radish peroxidase, and the substrate comprises peroxide.

8. An isolated antibody or fragment thereof that specifically binds to one or more epitopes of hepcidin located within amino acids 70-84 of SEQ ID NO: 2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2004
From: GAECINTOV, CYRIL E.; KULAKSIZ, HASSAN; STREMMEL, WOLFGANG; JANETZKO, ALFRED
To: DRG INTERNATIONAL, INC.
Reel/Frame 015849/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2004
From: GEACINTOV, CYRIL E.; KULAKSIZ, HASAN; STREMMEL, WOLFGANG; JANETZKO, ALFRED
To: DRG INTERNATIONAL, INC.
Reel/Frame 015869/0047 →
Continuity (2)
Continuation In Part 1029948600 · Nov 19, 2002
Related Publication 20040096990A1 · May 20, 2004